Company / EPS (Basic)
BIOMERICA INC EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$2.84
FY2025
5-year range
-$2.84 / -$0.23
FY2021-FY2025
Trend
-468.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Basic) changed -468% YoY in FY2025, a notable deviation from the 9-year average annual change of -121%.
Based on SEC 10-K filings.
-2.84 in FY2025.
Declined from $-0.36 to $-2.84 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) decreased 468.0% year-over-year.
- Peak eps (basic) was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.84 | -468.0% |
| FY2024 | -$0.50 | -38.9% |
| FY2023 | -$0.36 | +41.9% |
| FY2022 | -$0.62 | -169.6% |
| FY2021 | -$0.23 | +11.5% |
| FY2020 | -$0.26 | -52.9% |
| FY2019 | -$0.17 | -54.5% |
| FY2018 | -$0.11 | +45.0% |
| FY2017 | -$0.20 | -400.0% |
| FY2016 | -$0.04 | -33.3% |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026